- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cedara prepares Asian initiative
B-Soft Group, a leading vendor of HIS products in China, has signed with Canadian PACS developer Cedara to sell that company's PACS products. Under an agreement signed Nov. 5, B-Soft and Cedara will cooperatively develop an integrated hospital
B-Soft Group, a leading vendor of HIS products in China, has signed with Canadian PACS developer Cedara to sell that company's PACS products. Under an agreement signed Nov. 5, B-Soft and Cedara will cooperatively develop an integrated hospital information and image management system that provides a complete solution tailored to workflow in Chinese hospitals. The deal is a milestone in Cedara's strategic plans to expand business in China.
Other efforts include a cooperative agreement signed in late November with Hong Kong Polytechnic University to deploy Cedara's PACS. The university is expected to provide Cedara with a clinical environment where it can display its technology to potential customers, offer training, and learn more about regional workflow requirements. Funding from the Canadian International Development Agency will help defray costs of penetrating the Chinese market, providing some 80% of the expense of developing a business plan for the development of Chinese medical IT products and services.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
